(Total Views: 309)
Posted On: 12/20/2021 11:05:49 AM
Post# of 85472
$ZGNX News Article - Zogenix Submits Type II Variation Application to the European Medicines Agency (EMA) to Expand the Use of FINTEPLA (Fenfluramine) for the Treatment of Seizures Associated with Lennox-Gastaut Syndrome https://marketwirenews.com/news-releases/zoge...26152.html
(0)
(0)
My Twitter: WhyteStocks
